missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ AMID Antibody (Pab122), Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals™ NBP3-30820-100ug
This item is not returnable.
View return policy
Description
AMID Monoclonal antibody specifically detects AMID in Hamster,Human,Monkey,Mouse,Rat samples. It is validated for Flow Cytometry,Immunoprecipitation,Western Blot,Immunohistochemistry (Paraffin),Immunohistochemistry (Frozen),Immunocytochemistry/ Immunofluorescence
Specifications
| AMID | |
| Monoclonal | |
| Unconjugated | |
| Phosphate buffered saline | |
| Mouse | |
| Protein A or G purified | |
| RUO | |
| Primary | |
| Hamster, Human, Monkey, Mouse, Rat | |
| Purified |
| Flow Cytometry, Immunoprecipitation, Western Blot, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), Immunocytochemistry/Immunofluorescence | |
| Pab122 | |
| Western Blot : 5-10 μg/mL, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation : 2 μg/mg of protein lysate, Immunohistochemistry-Paraffin : 1-2 μg/mL, Immunohistochemistry-Frozen : 1-2 μg/mL | |
| AMID, apoptosis-inducing factor (AIF)-like mitochondrion-associated inducer of death, apoptosis-inducing factor 2, Apoptosis-inducing factor homologous mitochondrion-associated inducer of death, apoptosis-inducing factor, mitochondrion-associated, 2, Apoptosis-inducing factor-like mitochondrion-associated inducer of death, DKFZp686L1298, FLJ14497, p53-responsive gene 3 protein, PRG3apoptosis-inducing factor (AIF)-homologous mitochondrion-associated inducer ofdeath, RP11-367H5.2 | |
| Hybridoma produced by the fusion of splenocytes from immunized with full length mouse AMID protein and mouse myeloma cells. | |
| 100 μg | |
| Apoptosis, Cancer, Tumor Suppressors | |
| 84883 | |
| Store at -20°C. Avoid freeze/thaw cycles. | |
| IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction